Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle

运动和骨骼肌 PGC-1 共激活剂对线粒体的调节

基本信息

  • 批准号:
    9124710
  • 负责人:
  • 金额:
    $ 12.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-13 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exercise has been shown to be a powerful intervention for the treatment of many diseases that affect muscle function. The positive effects of exercise are largely considered to be the result of changes in both the number and functionality of mitochondria. The ways in which exercise mediates the changes in mitochondria are poorly understood. Members of the peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family of coactivators have been identified as being important to both normal muscle and mitochondria function. It is widely suggested that PGC-1� is responsible for most, if not all, of these changes in response to exercise. However, we observe that deletion of PGC-1� in skeletal muscle does not affect the adaptive changes in mitochondrial parameters. These data show that PGC-1� is not required for exercise-induced changes in mitochondria. In addition, the role that mitochondrial dynamics (fusion/fission) in improving muscle function in response to exercise is unknown and its contribution to removing bad and damaged mitochondria is unstudied. These observations reveal that our understanding of exercise-induced changes in skeletal muscle is incomplete. Therefore, the overall objective of this proposal is to understand how exercise and the PGC-1s affect mitochondria number and dynamics to improve muscle performance. Using genetic models, cellular imaging and mitochondrial assays we will attempt to address these very important questions. Results from this proposal have broad implications for our understanding of the benefits of exercise in the treatment of mitochondrial disorders. The specific aims are to: 1) determine the contribution of PGC-1� and � in regulating exercise-induced mitochondrial biogenesis; 2) determine the role of exercise and PGC-1� and � in regulating mitochondrial fusion and fission; 3) test if fusion/fission is involved in the dramatic improvement conferred by exercise seen with advance aging. The candidate is completing his postdoctoral training in the Cardiovascular Institute (CVI) at Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School. His primary mentor is Dr. Zoltan Arany, Assistant Professor of Medicine, with extensive experience in PGC-1 coactivators, molecular biology and metabolism. His co-mentor is Dr. Laurie Goodyear, Associate Professor of Medicine, a world-renowned expert in exercise physiology and skeletal muscle. The candidate's long-term career goal is to establish an independent research program in exercise physiology and mitochondrial dynamics. To accomplish this goal, he has created a series of short-term goals designed to enhance his knowledge of mitochondrial function, skeletal muscle, exercise physiology and advanced imaging technology, which will be facilitated by his mentorship oversight team and a comprehensive career development plan. Results from this proposal will serve as the foundation and preliminary data for an R series proposal such as an R01 within 3-5 years.
描述(由申请人提供):运动已被证明是治疗许多影响肌肉功能的疾病的有力干预措施。运动的积极作用在很大程度上被认为是线粒体数量和功能变化的结果。运动介导线粒体变化的方式尚不清楚。过氧化物酶体增殖体激活受体γ共激活因子-1 (PGC-1)家族的成员已被确定为对正常肌肉和线粒体功能都很重要。人们普遍认为,PGC-1对运动后的这些变化负有大部分责任,如果不是全部的话。然而,我们观察到骨骼肌中PGC-1的缺失并不影响线粒体参数的适应性变化。这些数据表明,运动引起的线粒体变化并不需要PGC-1。此外,线粒体动力学(融合/裂变)在改善运动后肌肉功能中的作用尚不清楚,其对去除不良和受损线粒体的贡献也未得到研究。这些观察结果表明,我们对运动引起的骨骼肌变化的理解是不完整的。因此,本提案的总体目标是了解运动和PGC-1s如何影响线粒体数量和动力学以提高肌肉表现。利用遗传模型、细胞成像和线粒体分析,我们将尝试解决这些非常重要的问题。这一建议的结果对我们理解运动在治疗线粒体疾病中的益处具有广泛的意义。具体目的是:1)确定PGC-1和PGC-1在调节运动诱导的线粒体生物发生中的作用;2)确定运动和PGC-1和PGC-1在调节线粒体融合和裂变中的作用;3)核聚变/裂变试验

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Glenn Cameron Rowe其他文献

Glenn Cameron Rowe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Glenn Cameron Rowe', 18)}}的其他基金

Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10615236
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10296083
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10469480
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Regulation of Skeletal Muscle Mitochondrial Quality Control Parameters and Systemic Metabolism
骨骼肌线粒体质量控制参数和全身代谢的调节
  • 批准号:
    9905516
  • 财政年份:
    2019
  • 资助金额:
    $ 12.45万
  • 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌 PGC-1 共激活剂对线粒体的调节
  • 批准号:
    9014362
  • 财政年份:
    2015
  • 资助金额:
    $ 12.45万
  • 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌 PGC-1 共激活剂对线粒体的调节
  • 批准号:
    8374349
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌中 PGC-1 共激活剂对线粒体的调节
  • 批准号:
    8544780
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 12.45万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 12.45万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 12.45万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 12.45万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了